Vaginal Misoprostol vs. Dinoprostone Compared for Labor Induction in Term Pregnancies

Inducing labor in pregnancies with an unfavorable cervix (Bishop score ≤7) often requires sequential use of multiple agents. Current standard practices utilize prostaglandins like dinoprostone (a prostaglandin E2 analog) and misoprostol (a prostaglandin E1 analog) to ripen the cervix and stimulate contractions. However, a clear consensus on the optimal subsequent ripening method after initial dinoprostone use, or a direct comparison of these agents' effectiveness and safety in term pregnancies, remains a critical gap in obstetrics. This research aims to address this by comparing these common induction methods.

This single-center retrospective cohort study investigated methods for labor induction in pregnancies with unfavorable cervices. The primary comparison focused on the effectiveness and safety of vaginal misoprostol versus dinoprostone. The study also considered the potential role of oxytocin as a third agent or in combination, and mentioned the use of a double-balloon catheter (DBC) alone or combined with these pharmacological agents. The study population included women in late- and post-term pregnancies, though the primary title suggests a focus on term pregnancies. Primary endpoints included labor duration and the incidence of various obstetric complications.

The provided abstract and supporting text did not include any specific results, numerical data, p-values, or statistical comparisons regarding labor duration, obstetric complications, or the comparative effectiveness and safety of misoprostol versus dinoprostone. Therefore, no findings can be reported from this abstract.